Beyond Air, Inc. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
Beyond Air, Inc. (XAIR) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of $2.84 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2026-08-13
- 2026-06-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $2.84M.
- 2026-03-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $6.21M.
- 2025-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $8.29M.
- 2025-09-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $13.10M.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest |
|---|---|
| 2026-06-30 | $2.84M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $6.21M 10-Q · filed 2026-08-13 |
| 2025-12-31 | $8.29M 10-Q · filed 2026-02-13 |
| 2025-09-30 | $13.10M 10-Q · filed 2026-02-13 |
| 2025-06-30 | $10.41M 10-Q · filed 2026-08-13 |
| 2025-03-31 | $14.34M 10-Q · filed 2026-08-13 |
| 2024-12-31 | $18.38M 10-Q · filed 2026-02-13 |
| 2024-09-30 | $29.29M 10-Q · filed 2026-02-13 |
| 2024-06-30 | $17.70M 10-Q · filed 2026-02-13 |
| 2024-03-31 | $27.19M 10-K · filed 2026-06-26 |
| 2023-12-31 | $23.47M 10-Q · filed 2025-02-10 |
| 2023-09-30 | $28.83M 10-Q · filed 2025-02-10 |
| 2023-06-30 | $39.14M 10-Q · filed 2025-02-10 |
| 2023-03-31 | $42.03M 10-K · filed 2025-06-20 |
| 2022-12-31 | $55.44M 10-Q · filed 2024-02-12 |
| 2022-09-30 | $63.65M 10-Q · filed 2024-02-12 |
| 2022-06-30 | $71.35M 10-Q · filed 2024-02-12 |
| 2022-03-31 | $78.21M 10-K · filed 2024-06-24 |
| 2021-12-31 | $90.77M 10-Q · filed 2023-02-10 |
| 2021-09-30 | $40.92M 10-Q · filed 2023-02-10 |
| 2021-06-30 | $33.45M 10-Q · filed 2023-02-10 |
| 2021-03-31 | $30.46M 10-K · filed 2023-06-22 |
| 2020-12-31 | $17.21M 10-Q · filed 2022-02-10 |
| 2020-09-30 | $16.13M 10-Q · filed 2022-02-10 |
| 2020-06-30 | $18.24M 10-Q · filed 2022-02-10 |
| 2020-03-31 | $18.09M 10-K · filed 2022-06-29 |
| 2017-09-30 | -$6.87M 10-Q · filed 2017-11-03 |
| 2017-06-30 | -$188.00K 10-Q · filed 2017-08-11 |
| 2017-03-31 | $872.00K 10-Q · filed 2017-05-15 |
| 2016-12-31 | -$4.70M 10-Q · filed 2017-11-03 |
| 2015-12-31 | -$1.82M 10-Q · filed 2017-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |